Trial intelligence / Profile preview

Clopidogrel versus Aspirin in Chronic Heart Failure

2009-011637-27Phase 4Terminated

Sponsor
Hull University Teaching Hospitals
Start
Jul 2010
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial in chronic heart failure (CHF) comparing Clopidogrel 75 mg/day with Aspirin 75 mg/day (2 arms). Primary endpoint: All-cause mortality. Started Jul 2010; status: terminated.

02

Drugs

clopidogrelaspirin
03

Conditions

chronic heart failure (CHF)

Beyond the preview

Go deeper on 2009-011637-27.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2009-011637-27.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call